Finance

Lists
BIOSGN:STO
Biosergen AB
SEK 0.54
-0.91%
(-0.0050) 1D
Sep 18, 5:29:33 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for BIOSGN...
Open
SEK 0.55
High
SEK 0.56
Low
SEK 0.54
Mkt. cap
44.79M
Avg. vol.
647.59K
Volume
0.00
52-wk high
SEK 7.30
52-wk low
SEK 0.47
EPS
-SEK 1.52
Shares outstanding
2.35M
No. of employees
1
Open
SEK 0.55
High
SEK 0.56
Low
SEK 0.54
Mkt. cap
44.79M
Avg. vol.
647.59K
Volume
0.00
52-wk high
SEK 7.30
52-wk low
SEK 0.47
EPS
-SEK 1.52
Shares outstanding
2.35M
No. of employees
1
About Biosergen AB
CEOTine Kold Olesen
Employees1
Founded2004
Headquarters-
SectorBiotechnology
Websitebiosergen.net
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
131.00K
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.73M
5.88M
5.33M
5.33M
Operating expense
12.19M
9.67M
5.24M
5.24M
Total operating expenses
12.19M
9.67M
5.24M
5.24M
Operating income
-12.19M
-9.67M
-5.24M
-5.24M
Other non operating income
-
-
-
-
EBT including unusual items
-12.17M
-9.66M
-5.24M
-5.24M
EBT excluding unusual items
-12.17M
-9.66M
-5.24M
-5.24M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-537.00K
3.79M
-95.50K
-95.50K
Net income
-12.17M
-9.66M
-5.24M
-5.24M
Net profit margin
-
-
-
-
Earnings per share
-5.00
-
-
-
Interest and investment income
22.00K
18.00K
-
-
Interest expense
-
-4.00K
-7.50K
-7.50K
Net interest expenses
22.00K
14.00K
-7.50K
-7.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps